Expression of fucosyltransferase 8 is associated with an unfavorable clinical outcome in non-small cell lung cancers

Oncology (Switzerland)

Volumn 88, Issue 5, 2015, Pages 298-308

  Honma, Rio ^a   Kinoshita, Ichiro ^a   Miyoshi, Eiji ^c   Tomaru, Utano ^a   Matsuno, Yoshihiro ^b   Shimizu, Yasushi ^a   Takeuchi, Satoshi ^a   Kobayashi, Yuka ^d   Kaga, Kichizo ^a   Taniguchi, Naoyuki ^e   Dosaka Akita, Hirotoshi ^a  

^a HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b HOKKAIDO UNIVERSITY HOSPITAL   (Japan)

^c OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d J Oil Mills Inc   (Japan)

^e RIKEN   (Japan)

Author keywords

Fucosyltransferase 8; Histology; Non small cell lung cancers; Prognosis

Indexed keywords

FUCOSYLTRANSFERASE; FUCOSYLTRANSFERASE 8; GUANOSINE DIPHOSPHATE MANNOSE; UNCLASSIFIED DRUG; GLYCOPROTEIN 6-ALPHA-L-FUCOSYLTRANSFERASE; HYDROLYASE;

ADULT; ARTICLE; CANCER PROGNOSIS; CANCER SURGERY; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; NON SMALL CELL LUNG CANCER; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; ADENOCARCINOMA; AGED; CANCER STAGING; ENZYMOLOGY; EPIDEMIOLOGY; GENE EXPRESSION REGULATION; GENETICS; JAPAN; KAPLAN MEIER METHOD; LUNG; LUNG TUMOR; METABOLISM; MIDDLE AGED; MORTALITY; PATHOLOGY; PREDICTIVE VALUE; PROGNOSIS; RISK ASSESSMENT; RISK FACTOR; TUMOR CELL LINE; WESTERN BLOTTING;

ADENOCARCINOMA; AGED; BLOTTING, WESTERN; CARCINOMA, NON-SMALL-CELL LUNG; CELL LINE, TUMOR; FEMALE; FUCOSYLTRANSFERASES; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; GUANOSINE DIPHOSPHATE MANNOSE; HUMANS; HYDRO-LYASES; IMMUNOHISTOCHEMISTRY; JAPAN; KAPLAN-MEIER ESTIMATE; LUNG; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RISK ASSESSMENT; RISK FACTORS;

EID: 84929031237     PISSN: 00302414     EISSN: 14230232     Source Type: Journal    
DOI: 10.1159/000369495     Document Type: Article

References (30)

1. NSCLC Meta-Analyses Collaborative Group: Chemotherapy in addition to supportive care improves survival in advanced non-small-cell lung cancer: A systematic review and metaanalysis of individual patient data from 16 randomized controlled trials. J Clin Oncol 2008; 26: 4617-4625.
2. Grossi F, Aita M, Defferrari C, Rosetti F, Brianti A, Fasola G, Vinante O, Pronzato P, Pappagallo G: Impact of third-generation drugs on the activity of first-line chemotherapy in advanced non-small cell lung cancer: A metaanalytical approach. Oncologist 2009; 14: 497-510.
3. Kaufman J, Horn L, Carbone D: Molecular biology of lung cancer; in DeVita VT Jr, Lawrence TS, Rosenberg SA (eds): Cancer: Principles and Practice of Oncology, ed 9. Philadelphia, Lippincott Williams & Wilkins, 2011, pp 789-798.
4. Hanahan D, Weinberg RA: Hallmarks of cancer: the next generation. Cell 2011; 144: 646-674.
5. Dosaka-Akita H, Hommura F, Mishina T, Ogura S, Shimizu M, Katoh H, Kawakami Y: A risk-stratification model of non-small cell lung cancers using cyclin E, Ki-67, and ras p21: different roles of G1 cyclins in cell proliferation and prognosis. Cancer Res 2001; 61: 2500-2504.
6. Pao W, Girard N: New driver mutations in non-small-cell lung cancer. Lancet Oncol 2011; 12: 175-180.
7. Gold KA, Wistuba II, Kim ES: New strategies in squamous cell carcinoma of the lung: identification of tumor drivers to personalize therapy. Clin Cancer Res 2012; 18: 3002-3007.
8. Gibbs JB: Mechanism-based target identification and drug discovery in cancer research. Science 2000; 287: 1969-1973.
9. Hart GW, Copeland RJ: Glycomics hits the big time. Cell 2010; 143: 672-676.
10. Hakomori S: Aberrant glycosylation in tumors and tumor-associated carbohydrate antigens. Adv Cancer Res 1989; 52: 257-331.
11. Varki A: Biological roles of oligosaccharides: All of the theories are correct. Glycobiology 1993; 3: 97-130.
12. Dwek RA: Glycobiology: Toward understanding the function of sugars. Chem Rev 1996; 96: 683-720.
13. Lau KS, Dennis JW: N-Glycans in cancer progression. Glycobiology 2008; 18: 750-760.
14. Miyoshi E, Noda K, Yamaguchi Y, Inoue S, Ikeda Y, Wang W, Ko JH, Uozumi N, Li W, Taniguchi N: The alpha1-6-fucosyltransferase gene and its biological significance. Biochim Biophys Acta 1999; 1473: 9-20.
15. Ito Y, Miyauchi A, Yoshida H, Uruno T, Nakano K, Takamura Y, Miya A, Kobayashi K, Yokozawa T, Matsuzuka F, Taniguchi N, Matsuura N, Kuma K, Miyoshi E: Expression of alpha1,6-fucosyltransferase (FUT8) in papillary carcinoma of the thyroid: its linkage to biological aggressiveness and anaplastic transformation. Cancer Lett 2003; 200: 167-172.
16. Hutchinson WL, White YS, Fagan EA, Johnson PJ, Williams R: Impaired binding properties of thyroxine-binding globulin in hepatocellular carcinoma and chronic liver disease. Hepatology 1991; 14: 116-120.
17. Takahashi T, Ikeda Y, Miyoshi E, Yaginuma Y, Ishikawa M, Taniguchi N: Alpha 1,6 fucosyltransferase is highly and specifically expressed in human ovarian serous adenocarcinomas. Int J Cancer 2000; 88: 914-919.
18. Muinelo-Romay L, Vazquez-Martin C, Villar-Portela S, Cuevas E, Gil-Martin E, Fernandez-Briera A: Expression and enzyme activity of alpha(1,6)fucosyltransferase in human colorectal cancer. Int J Cancer 2008; 123: 641-646.
19. Becker DJ, Lowe JB: Fucose: Biosynthesis and biological function in mammals. Glycobiology 2003; 13: 41R-53R.
20. Ohyama C, Smith PL, Angata K, Fukuda MN, Lowe JB, Fukuda M: Molecular cloning and expression of GDP-D-mannose-4,6-dehydratase, a key enzyme for fucose metabolism defective in Lec13 cells. J Biol Chem 1998; 273: 14582-14587.
21. Beahrs O, Henson D, Hutter R, Kennedy B (eds): Lung; in: Manual for Staging of Cancer, ed 4. Chicago, American Joint Committee on Cancer, 1992, pp 115-122.
22. Moriwaki K, Noda K, Nakagawa T, Asahi M, Yoshihara H, Taniguchi N, Hayashi N, Miyoshi E: A high expression of GDP-fucose transporter in hepatocellular carcinoma is a key factor for increases in fucosylation. Glycobiology 2007; 17: 1311-1320.
23. Kobayashi Y, Tateno H, Dohra H, Moriwaki K, Miyoshi E, Hirabayashi J, Kawagishi H: A novel core fucose-specific lectin from the mushroom Pholiota squarrosa . J Biol Chem 2012; 287: 33973-33982.
24. Nakahara S, Saito T, Kondo N, Moriwaki K, Noda K, Ihara S, Takahashi M, Ide Y, Gu J, Inohara H, Katayama T, Tohyama M, Kubo T, Taniguchi N, Miyoshi E: A secreted type of beta1,6 N-acetylglucosaminyltransferase V (GnT-V), a novel angiogenesis inducer, is regulated by gamma-secretase. FASEB J 2006; 20: 2451-2459.
25. Dosaka-Akita H, Miyoshi E, Suzuki O, Itoh T, Katoh H, Taniguchi N: Expression of Nacetylglucosaminyltransferase V is associated with prognosis and histology in non-small cell lung cancers. Clin Cancer Res 2004; 10: 1773-1779.
26. Wang X, Gu J, Ihara H, Miyoshi E, Honke K, Taniguchi N: Core fucosylation regulates epidermal growth factor receptor-mediated intracellular signaling. J Biol Chem 2006; 281: 2572-2577.
27. Wang X, Inoue S, Gu J, Miyoshi E, Noda K, Li W, Mizuno-Horikawa Y, Nakano M, Asahi M, Takahashi M, Uozumi N, Ihara S, Lee SH, Ikeda Y, Yamaguchi Y, Aze Y, Tomiyama Y, Fujii J, Suzuki K, Kondo A, Shapiro SD, Lopez-Otin C, Kuwaki T, Okabe M, Honke K, Taniguchi N: Dysregulation of TGF-beta1 receptor activation leads to abnormal lung development and emphysema-like phenotype in core fucose-deficient mice. Proc Natl Acad Sci USA 2005; 102: 15791-15796.
28. Chen CY, Jan YH, Juan YH, Yang CJ, Huang MS, Yu CJ, Yang PC, Hsiao M, Hsu TL, Wong CH: Fucosyltransferase 8 as a functional regulator of nonsmall cell lung cancer. Proc Natl Acad Sci USA 2013; 110: 630-635.
29. Muinelo-Romay L, Villar-Portela S, Cuevas Alvarez E, Gil-Martin E, Fernandez-Briera A: Alpha(1,6)fucosyltransferase expression is an independent prognostic factor for diseasefree survival in colorectal carcinoma. Hum Pathol 2011; 42: 1740-1750.
30. Takeda Y, Shinzaki S, Okudo K, Moriwaki K, Murata K, Miyoshi E: Fucosylated haptoglobin is a novel type of cancer biomarker linked to the prognosis after an operation in colorectal cancer. Cancer 2012; 118: 3036-3043.